GlassScriptPhysician profile
Neil P Superfon
NPI 1588610422
$5,728.66
in general payments reported to CMS, 2019-2025
32 companies · $876 in 2025
The $876 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $79.23 · 2021: $681 · 2022: $1,243 · 2023: $383 · 2024: $915 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.50 |
| Education | $171.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,285.60 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $507.58 | 2023-2025 | Tremfya, Simponi Aria, Stelara |
| Regeneron Healthcare Solutions, INC. | $434.38 | 2019-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $376.81 | 2019-2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $364.70 | 2019-2024 | Duobrii, Siliq |
| Genentech USA, INC. | $329.62 | 2019 | |
| Ucb, INC. | $307.89 | 2019-2025 | Bimzelx |
| Lilly USA, LLC | $298.66 | 2019-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $273.21 | 2019-2025 | |
| Amgen INC. | $223.91 | 2019-2025 | Otezla, Otezla |
| Incyte Corporation | $148.77 | 2022 | |
| Pfizer INC. | $136.03 | 2019-2024 | |
| Pharming Healthcare, INC. | $127.38 | 2021-2025 | Ruconest |
| Celgene Corporation | $126.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.01 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $106.27 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $76.25 | 2021-2023 | Odomzo, Blu-U |
| Mimedx Group, INC. | $70.69 | 2024-2025 | |
| Leo Pharma INC. | $65.42 | 2019-2022 | |
| Organogenesis INC. | $58.42 | 2021-2025 | Puraply Wound Matrix |
| Protega Pharmaceutials INC | $43.63 | 2025 | Roxybond |
| Organon LLC | $40.55 | 2025 | Vtama |
| Bioventus LLC | $35.30 | 2022 | |
| Strata Skin Sciences, INC. | $31.79 | 2025 | Xtrac |
| Sensus Healthcare, INC. | $23.96 | 2021 | |
| Prugen, INC. Pharmaceuticals | $21.67 | 2019 | |
| Verrica Pharmaceuticals INC. | $21.11 | 2024 | Ycanth |
| Epi Health, LLC | $16.42 | 2022 | |
| Mayne Pharma Commercial LLC | $15.89 | 2025 | |
| Dermavant Sciences, INC. | $14.73 | 2023 | Vtama |
| Allergan, INC. | $12.72 | 2021 | |
| Advanced Oxygen Therapy INC. | $12.08 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Superfon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.